• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞移动抑制因子(MIF)和锰超氧化物歧化酶(MnSOD)作为严重脓毒症或脓毒性休克患者生存的早期预测指标。

Macrophage migration inhibitory factor (MIF) and manganese superoxide dismutase (MnSOD) as early predictors for survival in patients with severe sepsis or septic shock.

机构信息

Department of Anesthesiology, University of Heidelberg, Heidelberg, Germany.

出版信息

J Surg Res. 2010 Nov;164(1):e163-71. doi: 10.1016/j.jss.2010.05.004. Epub 2010 Jun 1.

DOI:10.1016/j.jss.2010.05.004
PMID:20863520
Abstract

BACKGROUND

Severe sepsis, septic shock, and resulting organ failure appear as the most common cause of death in intensive care medicine. Inflammatory mediators (interleukin-6/IL-6), cell adhesion molecules (intercellular adhesion molecule-1/ICAM-1, vascular cell adhesion molecule-1/VCAM-1), and redox active substances (manganese superoxide dismutase/MnSOD, macrophage migration inhibitory factor/MIF) must be considered to be central hubs in the inflammatory process. However, their exact pathophysiologic function and prognostic value are still poorly understood.

MATERIALS AND METHODS

In total, 133 individuals (87 patients with severe sepsis or septic shock, 28 postoperative patients after major abdominal surgery, 18 healthy volunteers) were enrolled in the study. Blood samples from septic patients were collected within 24 h after the time of sepsis diagnosis, and 48 and 120 h later; samples from healthy volunteers were collected once, and samples from postoperative patients once immediately after surgery. In all patients we measured plasma levels of IL-6, sICAM-1, sVCAM-1, MnSOD, and MIF using enzyme linked immunosorbent assay (ELISA) kits.

RESULTS

Healthy volunteers and postoperative patients showed comparable levels of cell adhesion molecules. Furthermore, their redox system was activated in a comparable manner, whereas in postoperative patients IL-6 was significantly elevated. Plasma levels of inflammatory mediators, cell adhesion molecules and redox active substances were significantly elevated in septic patients. In patients with sepsis who had died, plasma levels of MIF and MnSOD were significantly elevated in comparison with survivors.

CONCLUSIONS

Our results therefore demonstrate that redox active substances may play an important role in the septic inflammatory response. MIF and MnSOD appear to be early predictors for survival in septic patients.

摘要

背景

严重脓毒症、感染性休克和由此导致的器官衰竭是重症监护医学中最常见的死亡原因。炎症介质(白细胞介素 6/IL-6)、细胞黏附分子(细胞间黏附分子 1/ICAM-1、血管细胞黏附分子 1/VCAM-1)和氧化还原活性物质(锰超氧化物歧化酶/MnSOD、巨噬细胞移动抑制因子/MIF)被认为是炎症过程中的核心枢纽。然而,它们的确切病理生理功能和预后价值仍知之甚少。

材料和方法

本研究共纳入 133 名个体(87 名严重脓毒症或感染性休克患者、28 名大型腹部手术后患者、18 名健康志愿者)。脓毒症患者的血液样本在脓毒症诊断后 24 小时内采集,并在 48 小时和 120 小时后再次采集;健康志愿者的样本仅采集一次,术后患者的样本在手术后立即采集一次。在所有患者中,我们使用酶联免疫吸附试验(ELISA)试剂盒测量了血浆中白细胞介素 6(IL-6)、可溶性细胞间黏附分子 1(sICAM-1)、可溶性血管细胞黏附分子 1(sVCAM-1)、MnSOD 和 MIF 的水平。

结果

健康志愿者和术后患者的细胞黏附分子水平相当。此外,他们的氧化还原系统以类似的方式被激活,而术后患者的白细胞介素 6(IL-6)显著升高。脓毒症患者的炎症介质、细胞黏附分子和氧化还原活性物质的血浆水平显著升高。与存活患者相比,死亡患者的血浆 MIF 和 MnSOD 水平显著升高。

结论

因此,我们的研究结果表明氧化还原活性物质可能在脓毒症炎症反应中发挥重要作用。MIF 和 MnSOD 似乎是脓毒症患者生存的早期预测指标。

相似文献

1
Macrophage migration inhibitory factor (MIF) and manganese superoxide dismutase (MnSOD) as early predictors for survival in patients with severe sepsis or septic shock.巨噬细胞移动抑制因子(MIF)和锰超氧化物歧化酶(MnSOD)作为严重脓毒症或脓毒性休克患者生存的早期预测指标。
J Surg Res. 2010 Nov;164(1):e163-71. doi: 10.1016/j.jss.2010.05.004. Epub 2010 Jun 1.
2
Time course of endothelial damage in septic shock: prediction of outcome.脓毒性休克中内皮损伤的时间进程:结局预测
Crit Care. 2005 Aug;9(4):R323-30. doi: 10.1186/cc3532. Epub 2005 May 13.
3
Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.巨噬细胞移动抑制因子(MIF)在脑膜炎球菌性败血症及实验性人类内毒素血症中的作用
Shock. 2007 May;27(5):482-7. doi: 10.1097/01.shk.0000246898.65692.34.
4
Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis.严重脓毒症患者血液中巨噬细胞移动抑制因子水平升高、肾上腺反应异常与早期死亡之间的关联。
Clin Infect Dis. 2007 May 15;44(10):1321-8. doi: 10.1086/514344. Epub 2007 Apr 5.
5
Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever.克里米亚-刚果出血热血管内皮损伤的证据。
Int J Infect Dis. 2010 Aug;14(8):e704-7. doi: 10.1016/j.ijid.2010.02.2240.
6
Elevated nucleosome levels in systemic inflammation and sepsis.全身炎症和脓毒症中核小体水平升高。
Crit Care Med. 2003 Jul;31(7):1947-51. doi: 10.1097/01.CCM.0000074719.40109.95.
7
Levels of soluble adhesion molecules and cytokines in patients with septic multiple organ failure.脓毒症多器官功能衰竭患者可溶性黏附分子和细胞因子水平
J Inflamm. 1995;46(4):212-9.
8
Plasma profiles of circulating granulocyte-macrophage colony-stimulating factor and soluble cellular adhesion molecules in acute myocardial infarction. Contribution to post-infarction left ventricular dysfunction.急性心肌梗死时循环中粒细胞-巨噬细胞集落刺激因子和可溶性细胞黏附分子的血浆水平。对梗死后左心室功能障碍的影响。
Eur Cytokine Netw. 2004 Apr-Jun;15(2):139-44.
9
Increases in serum macrophage migration inhibitory factor in patients with severe sepsis predict early mortality.严重脓毒症患者血清巨噬细胞移动抑制因子水平升高预示早期死亡。
Shock. 2007 May;27(5):503-6. doi: 10.1097/SHK.0b013e31802c024b.
10
Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.血液透析程序不影响终末期肾病患者的可溶性细胞间黏附分子-1(sICAM-1)和可溶性血管细胞黏附分子-1(sVCAM-1)水平。
Ren Fail. 2005;27(3):315-21.

引用本文的文献

1
ICAM1 and VCAM1 are associated with outcome in patients with sepsis: A systematic review and meta-analysis.ICAM1和VCAM1与脓毒症患者的预后相关:一项系统评价和荟萃分析。
Heliyon. 2024 Oct 31;10(21):e40003. doi: 10.1016/j.heliyon.2024.e40003. eCollection 2024 Nov 15.
2
Distinct patterns of serum and urine macrophage migration inhibitory factor kinetics predict death in sepsis: a prospective, observational clinical study.血清和尿液巨噬细胞迁移抑制因子动力学的不同模式可预测脓毒症患者的死亡:一项前瞻性、观察性临床研究。
Sci Rep. 2023 Jan 11;13(1):588. doi: 10.1038/s41598-023-27506-6.
3
MIF but not MIF-2 recruits inflammatory macrophages in an experimental polymicrobial sepsis model.
MIF 而非 MIF-2 在实验性多微生物脓毒症模型中募集炎症性巨噬细胞。
J Clin Invest. 2021 Dec 1;131(23). doi: 10.1172/JCI127171.
4
Macrophage migration inhibitory factor as a diagnostic and predictive biomarker in sepsis: meta-analysis of clinical trials.巨噬细胞移动抑制因子作为脓毒症的诊断和预测生物标志物:临床试验的荟萃分析。
Sci Rep. 2021 Apr 13;11(1):8051. doi: 10.1038/s41598-021-87613-0.
5
Correlations of polymorphism and serum levels of MIF with glucocorticoid sensitivity of sudden sensorineural hearing loss.MIF 多态性与血清水平与突发性聋糖皮质激素敏感性的相关性。
J Int Med Res. 2020 Apr;48(4):300060519893870. doi: 10.1177/0300060519893870. Epub 2019 Dec 31.
6
Inflammatory mediators in intra-abdominal sepsis or injury - a scoping review.腹腔内脓毒症或损伤中的炎症介质——一项范围综述
Crit Care. 2015 Oct 27;19:373. doi: 10.1186/s13054-015-1093-4.
7
Sustained elevation of resistin, NGAL and IL-8 are associated with severe sepsis/septic shock in the emergency department.急诊科中抵抗素、中性粒细胞明胶酶相关脂质运载蛋白(NGAL)和白细胞介素-8(IL-8)的持续升高与严重脓毒症/脓毒性休克相关。
PLoS One. 2014 Oct 24;9(10):e110678. doi: 10.1371/journal.pone.0110678. eCollection 2014.
8
Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view.败血症中的细胞因子:强大的免疫调节剂和潜在的治疗靶点——更新的观点。
Mediators Inflamm. 2013;2013:165974. doi: 10.1155/2013/165974. Epub 2013 Jun 18.
9
Efficacy and safety of active negative pressure peritoneal therapy for reducing the systemic inflammatory response after damage control laparotomy (the Intra-peritoneal Vacuum Trial): study protocol for a randomized controlled trial.主动负压腹腔灌洗治疗在损伤控制性剖腹术后降低全身炎症反应的疗效和安全性(腹腔内真空试验):一项随机对照试验的研究方案。
Trials. 2013 May 16;14:141. doi: 10.1186/1745-6215-14-141.
10
Biomarkers in sepsis.脓毒症的生物标志物。
Curr Opin Pulm Med. 2013 May;19(3):305-9. doi: 10.1097/MCP.0b013e32835f1b49.